Effects of direct active-site anticoagulants on the fibrinolytic function of coagulation factor Xa
Treatment of occlusive clots (thrombi) is important for proper health yet systemic bleeding remains a major complication of thrombolytic therapy. Thus, the utility of agents such as alteplase, the current thrombolytic approved to rapidly lyse thrombi, is limited. As an alternative, our laboratory ha...
| Main Author: | |
|---|---|
| Language: | English |
| Published: |
University of British Columbia
2017
|
| Online Access: | http://hdl.handle.net/2429/63386 |